4.1 Letter

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres

Journal

THERAPIE
Volume 76, Issue 4, Pages 369-+

Publisher

ELSEVIER
DOI: 10.1016/j.therap.2021.05.007

Keywords

VaxZevria (R); Covid-19 vaccine; Pharmacovigilance; Atypical thrombosis; Thrombopenia; Anti-PF4 antibodies

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available